1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Jessica Cho made an unannounced subsequent visit for the purpose of continuing the investigation into the above allegation. LPA met with Executive Director Kyle Coleman and explained the reason for the visit and discussed the allegations. During the course of the investigation, LPA conducted a review of the medications and interviewed seven residents and five staff. Copies of documents pertinent to the allegation was obtained for review: Resident Rosters, Personnel Reports, Staff Contact Information, Face Sheets, Physician's Reports, medication cycle report, and Medication Administration Records.
The investigation revealed the following: Regarding the allegation, Staff are not properly managing the residents' medications, it is alleged Staff #2 (S2) would make repeated medication errors and was not reprimanded by S1. Based on the review of the medications, LPA observed a medication error for Resident #1 (R1). R1 was prescribed two prescription bottles of Spirinolactone- 100mg and 50mg filled on January 18, 2024. |